We are international
Donate
• treatment options TEXT SIZE   
bone disease    back

Bone Disease

Since patients may survive for many years post-diagnosis, clinicians have attempted to devise therapeutic approaches in myeloma that would relieve disabling symptoms, in particular severe bone pain, thereby improving quality of life. New therapies are still needed for myeloma bone disease. New targets have been identified and are being addressed in clinical trials.

Bone Disease in Multiple Myeloma
Dr. Brian Durie
Washington, DC 2009 Patient & Family Seminar
August 7-8, 2009
Bone Health in Focus
The significance of bone health in patients with multiple myeloma.

Kyphoplasty
Balloon kyphoplasty is a minimally invasive procedure that uses bone cement to stabilize the fracture, which in turn, reduces bone pain and helps increase the patient’s overall quality of life.
Bone disease and Bisphosphonate Therapy
Approximately 80% of all patients with myeloma develop bone disease. In addition to bone disease, myeloma patients may develop a condition called hypercalcemia. Both myeloma bone disease and hypercalcemia can be treated with a group of drugs called bisphosphonates.

Denosumab
Denosumab is a monoclonal antibody that inhibits RANKL (RANK ligand), a protein that promotes osteoclastic bone destruction.